Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI0382 in Overweight/Obese T2DM
NCT02548585Phase 2Completed
- Sponsor
- MedImmune
- Start
- Dec 2015
- Primary completion
- Feb 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cotadutide in type 2 diabetes mellitus (T2DM), obesity, sponsored by MedImmune. Started Dec 2015; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT02548585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02548585.